9
What do we need to know about active ingredients? Workshop #1

What do we need to know about active ingredients? Workshop #1

Embed Size (px)

Citation preview

Page 1: What do we need to know about active ingredients? Workshop #1

What do we need to know about active ingredients?

Workshop #1

Page 2: What do we need to know about active ingredients? Workshop #1

Discussion focus--Botanicals Question— Are traditional nutritional and

pharmacological approaches applicable to herbal supplements?

Multiple biologically active substances in products

Multiple biological activity endpoints

Page 3: What do we need to know about active ingredients? Workshop #1

Identifying meaningful components Meaningful = Components that

produce a biological effect Identification of meaningful

components should precede study of their bioavailability

Analytical chemistry databases inadequate for botanicals

Page 4: What do we need to know about active ingredients? Workshop #1

Analytical database development NAPRALERT, IBIDS—good sources,

need to expand knowledge base internationally

USDA databases as models

Page 5: What do we need to know about active ingredients? Workshop #1

Reference materials Standardized products needed for

research Dietary fiber & fish oil standard

products as models Industry should collaboratively

develop—nonproprietary, best first guess as to efficacy/safety

USP certification

Page 6: What do we need to know about active ingredients? Workshop #1

Clinical trials Need standard reference products Use classical approach (Phase I, II,

etc..) Determine priorities for clinical trials Selection criteria?

Extent of use Efficacy—target major public health

issues Safety

Page 7: What do we need to know about active ingredients? Workshop #1

Bioassays potential screening tools use with caution No substitute for clinical studies

Page 8: What do we need to know about active ingredients? Workshop #1

Biomarkers Little progress to date May be useful

Page 9: What do we need to know about active ingredients? Workshop #1

Summary Identification of meaningful

(bioactive) components should be the main focus

Bioavailability may be a key determinant of bioactivity

Need for standard reference materials Clinical studies should be based on

these 3 research areas